KREBSBIO — Krebs Biochemicals And Industries Cashflow Statement
0.000.00%
- IN₹1.70bn
- IN₹3.63bn
- IN₹504.22m
Annual cashflow statement for Krebs Biochemicals And Industries, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -289 | -284 | -445 | -247 | -197 |
Depreciation | |||||
Non-Cash Items | 55.6 | 65.5 | 51.1 | 32.6 | 51.2 |
Other Non-Cash Items | |||||
Changes in Working Capital | -172 | 21.1 | 159 | -98.4 | 101 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -359 | -146 | -172 | -247 | 23 |
Capital Expenditures | -94.1 | -255 | -271 | -152 | -94.2 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 3.65 | 29.6 | 41.8 | 25.1 | 16 |
Sale of Fixed Assets | |||||
Change in Net Intangibles | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -90.5 | -225 | -229 | -126 | -78.2 |
Financing Cash Flow Items | 36.7 | -62.8 | -53.9 | -29.7 | -46.9 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 278 | 377 | 395 | 373 | 55.6 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -171 | 5.36 | -6.1 | -0.148 | 0.516 |